entity

FPR2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about FPR2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

10Connections

0Hypotheses

1Analyses

8Outgoing

2Incoming

Wiki Pages (8)

Knowledge base pages for this entity

Outgoing (8)

Target	Relation	Type	Str
Ampk-Mtor Pathway	activates	pathway	0.90
AMPK-MTOR Pathway	activates	pathway	0.88
ANXA1	binds	protein	0.85
Annexin A1	interacts_with	protein	0.80
AMPK-mTOR Pathway	activates	pathway	0.80
AMPK	activates	protein	0.80
MTOR	regulates	protein	0.75
APP	binds	protein	0.75

Incoming (2)

Source	Relation	Type	Str
ANXA1	binds	protein	0.85
SAA	binds	protein	0.80

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Do SPM receptors undergo desensitization with chronic agonist treatment, prevent

pharmacology | 2026-04-11 | 0 hypotheses

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

FPR2

Understanding Entity Pages

Wiki Pages (8)

Section 188: Advanced Lipidomics and Membrane Therapy in CBS/PSP

Specialized Pro-Resolving Mediator (SPM) Therapies for Neurodegeneration

Specialized Pro-Resolving Mediator (SPM) Therapy for Neurodegeneration

omega-3-fatty-acid-signaling-neurodegeneration

Specialized Pro-Resolving Mediators in Neurodegeneration

Alzheimer's Disease Neuroimmune Resolution and Specialized Pro-Resolving Mediator Companies